Table 1 Demographic criteria and biochemical parameters in the studied groups.

From: Association of GAS6, AXL, and GAS6-AS lncRNAs with nephropathy in Egyptian patients with type 2 diabetes mellitus: a case–control observational study

 

Control (60)

DM (70)

DN (70)

Test statistic

p

Age (years)

40 (32–45)

44 (35–48)

42 (36-47.25)

2.202

0.113

Sex

   

4.738

0.094

 Male

40 (34.2%)

34 (29.1%)

43 (36.8%)

  

 Female

20 (24.1%)

36 (43.4%)

27 (32.5%)

  

BMI (kg/m2)

24 (21-26.23)

33 (30–36)a

22 (19-23.5)a,b

137.860

<0.0001

F_Glucose (mg/dL)

92 (75–97)

164 (138.5 -239)a

267.5 (205.75-302.5)a,b

138.184

<0.0001

HbA1c (%)

5.1 (4.5–5.4)

7.2 (6.7–8.23)a

8.5 (8.4–8.9)a,b

145.343

<0.0001

Creatinine

(mg/dL)

0.8 (0.7–1.06)

1.0 (0.7–1.2)

3.22 (2.8–4.13)a,b

137.690

<0.0001

Albuminuria

(mg/day)

4.15 (3.8–4.4)

5.5 (3.11–7.73)

58 (45–75)a,b

139.999

<0.0001

GAS6 (pg/mL)

251.6 (222.8–315.6)

211 (184.75–264)a

104.7 (84.03–125.33)a,b

132.857

<0.0001

AXL (pg/mL)

286.95 (241.7–339.18)

220.95 (166.15–259.35)a

94.2

(50.98–137.45)a,b

131.363

<0.0001

GAS6-AS1

(fold change)

1.0 (0.5–1.48)

1.3 (0.23–2.15)

1.6 (0.78–2.14)a

8.680

0.013

GAS6-DT

(fold change)

1.02 (0.26–2.35)

7.52 (4.45–9.03)a

16.54 (9.32–35.99)a,b

151.317

<0.0001

  1. Data are expressed as median (25th–75th percentile), analyzed by Kruskal–Wallis test, then pairwise post hoc Bonferroni comparisons, denoted as: “a” is significantly different from the control group, and “b” is significantly different from the DM group. Sex is expressed as count and percentage; n (%), compared by the chi-square test.
  2. DM diabetes mellitus group, DN diabetic nephropathy group, F fasting, HbA1c glycosylated hemoglobin.
  3. Significance was considered at p < 0.05 (two-tailed).